Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S29 pseudogene 8 (RPS29P8) is a processed pseudogene located on chromosome 2q23.1 with no exons and no evidence of protein-coding capacity[1][3][9]. It is related to the functional RPS29 gene, which encodes a structural protein of the 40S ribosomal subunit, but unlike RPS29, RPS29P8 does not produce a functional protein and is not implicated in any known biological function or disease process[1][3][9]. RPS29P8 is clearly annotated as a pseudogene in leading databases and gene resources[1][3][9]. This means it is a non-functional genomic element resembling the functional RPS29 gene but does not yield a biological product (protein or RNA) that would act as a therapeutic target. By convention, pseudogenes are not considered drug targets, receptors, enzymes, or components with biological activity unless new research has re-annotated them (which is not the case for RPS29P8 as of the most recent updates[1][9]). This distinguishes it from the functional RPS29 (ribosomal protein S29) gene, which encodes an essential ribosomal protein involved in translation and hematopoiesis. RPS29 is different from RPS29P8 and is not the same as the pseudogene[2][5][7]. In summary, RPS29P8 is a non-coding pseudogene and not a valid therapeutic target, receptor, or enzyme. There are no disease associations, relevant drugs, or mechanisms of action, and it serves no described biological or clinical role[1][3][9]. Any function, disease, or drug associations referred to in the literature relate to the parent gene RPS29, not to RPS29P8.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S29 pseudogene 8 (RPS29P8).